skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines alemtuzumabQuestion & answer

alemtuzumab · Medicine question

What type of medicine is alemtuzumab (Lemtrada)?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Lemtrada (alemtuzumab) is a monoclonal antibody produced using recombinant DNA technology.

Sources for this answer

LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §2 Qualitative and quantitative composition · Version 2Document updated 20 January 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

alemtuzumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about alemtuzumab

How much sodium and potassium does each Lemtrada (alemtuzumab) infusion contain?Has the safety and efficacy of Lemtrada (alemtuzumab) been established in children with multiple sclerosis?How is Lemtrada (alemtuzumab) administered, and how long does the infusion take?How often did serious infusion-associated reactions occur with Lemtrada (alemtuzumab) in multiple sclerosis clinical trials?Is Lemtrada (alemtuzumab) contraindicated in patients taking antiplatelet or anticoagulant therapy?

Read the alemtuzumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

What symptoms of pneumonitis have been reported after Lemtrada (alemtuzumab) infusions?